Interferon News and Research

RSS
New UK Guidance to be issued on Hepatitis C as 'silent epidemic'

New UK Guidance to be issued on Hepatitis C as 'silent epidemic'

Researchers discover how hepatic-C virus evades immune system in acute and chronic infections

Researchers discover how hepatic-C virus evades immune system in acute and chronic infections

Helix opens additional sites for its Topical Interferon Alpha-2b Phase II clinical study

Helix opens additional sites for its Topical Interferon Alpha-2b Phase II clinical study

Study shows using expanded critera donors is safe

Study shows using expanded critera donors is safe

New hope for people with hepatitis C

New hope for people with hepatitis C

Intralesional immunotherapy for common warts is effective and safe

Intralesional immunotherapy for common warts is effective and safe

New anticancer drug SU11248 shows continued response for patients with late-stage kidney cancer

New anticancer drug SU11248 shows continued response for patients with late-stage kidney cancer

Milk thistle not proven effective in lowering mortality in alcoholic or hepatitis B or C liver disease

Milk thistle not proven effective in lowering mortality in alcoholic or hepatitis B or C liver disease

Small number of genes can predict response to chronic hepatitis C therapy

Small number of genes can predict response to chronic hepatitis C therapy

Viramidine demonstrates anti-HCV Genotype 1 activity that compares favorably to Ribavirin

Viramidine demonstrates anti-HCV Genotype 1 activity that compares favorably to Ribavirin

Asthmatics naturally deficient in antiviral immunity

Asthmatics naturally deficient in antiviral immunity

New weapon for asthmatics to combat winter asthma attacks

New weapon for asthmatics to combat winter asthma attacks

Why respiratory viral infections are often more severe in people with asthma

Why respiratory viral infections are often more severe in people with asthma

European approval of Pegasys for the treatment of chronic hepatitis B

European approval of Pegasys for the treatment of chronic hepatitis B

Medical House signs 10 year license and supply agreement with BioPartners GmbH

Medical House signs 10 year license and supply agreement with BioPartners GmbH

Vaccine that boosts the immune response could improve the effect of conventional treatment for patients with chronic myeloid leukaemia

Vaccine that boosts the immune response could improve the effect of conventional treatment for patients with chronic myeloid leukaemia

Studies reveal methods viruses use to sidestep immune system

Studies reveal methods viruses use to sidestep immune system

Idiopathic pulmonary fibrosis study points to survival as key endpoint in future actimmune studies

Idiopathic pulmonary fibrosis study points to survival as key endpoint in future actimmune studies

Pegylated interferon alfa-2b offers the best treatment option for people with chronic hepatitis B infection

Pegylated interferon alfa-2b offers the best treatment option for people with chronic hepatitis B infection

Key molecule helps identify renal cell carcinoma

Key molecule helps identify renal cell carcinoma